Long-Term Follow-Up From Majestec-1 Of Teclistamab, A B-Cell Maturation Antigen (Bcma) X Cd3 Bispecific Antibody, In Patients With Relapsed/Refractory Multiple Myeloma (Rrmm)
Teclistamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Long-Term Follow-Up From Majestec-1 Of Teclistamab, A B-Cell Maturation Antigen (Bcma) X Cd3 Bispecific Antibody, In Patients With Relapsed/Refractory Multiple Myeloma (Rrmm) ### Output: Teclistamab